A new drug developed in Spain shows great potential against Rett Syndrome June 26, 2025 A new drug developed in Spain shows great potential against Rett Syndrome
Success of the first phase-2 clinical trial testing the new CAR-T technology against multiple myeloma March 26, 2021 Success of the first phase-2 clinical trial testing the new CAR-T technology against multiple myeloma
Emerging leaders in the field of immunity join together at the Josep Carreras Leukaemia Research Institute March 24, 2021 Emerging leaders in the field of immunity join together at the Josep Carreras Leukaemia Research Institute
The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia March 03, 2021 The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia
The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute February 25, 2021 The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute
Myelodysplastic Syndrome heterogeneity revealed using single cell technology February 23, 2021 Myelodysplastic Syndrome heterogeneity revealed using single cell technology
The Josep Carreras Institute organizes the Symposium "The Immune System: in sickness and in health" February 19, 2021 The Josep Carreras Institute organizes the Symposium "The Immune System: in sickness and in health"
Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosis February 19, 2021 Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosis
The Josep Carreras Institute opens a new Cell Immortalization Unit February 12, 2021 The Josep Carreras Institute opens a new Cell Immortalization Unit
Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girls February 11, 2021 Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girls
An international team measures the importance of the genetic background in cancer immunotherapy February 10, 2021 An international team measures the importance of the genetic background in cancer immunotherapy
